. "More cost-effective analyses and clinical trial research with male- and female-specific results are also needed, especially regarding risks posed by preventive therapies.???Now that science has shown the benefits are often similar for men and women, there is a need to understand if the risks are also similar and acceptable,??? she said.???These guidelines are a critical weapon in the war against h" . . .